Previously, oxLDL has been demonstrated to play a role in the development of DR since immunostaining of apolipoprotein B (apoB) oxLDL has been detected in the retinas of type 2 diabetic patients with or without DR and an increase in oxLDL levels reflects the severity of retinopathy [19]. This evidence concerns the gene APOB and retinal disorder.